Publications by authors named "Keith Finlayson"

Claim this Profile
C
Computational Fluorescence Suppression in Shifted Excitation Raman Spectroscopy.
Nia C Jenkins, Katjana Ehrlich, Andras Kufcsak, Stephanos Yerolatsitis, Susan Fernandes, Keith Finlayson

IEEE Trans Biomed Eng· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2 randomised placebo-controlled trial of spironolactone and dexamethasone versus dexamethasone in COVID-19 hospitalised patients in Delhi.
Bharti Wadhwa, Vikas Malhotra, Sukhyanti Kerai, Farah Husain, Nalini Bala Pandey, Keith Finlayson

BMC Infect Dis· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tri-mode optical biopsy probe with fluorescence endomicroscopy, Raman spectroscopy, and time-resolved fluorescence spectroscopy.
Harry Alexander Charles Wood, Katjana Ehrlich, Stephanos Yerolatsitis, András Kufcsák, Tom Michael Quinn, Keith Finlayson

J Biophotonics· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Specific immuno-imaging of pulmonary-resident memory lymphocytes in human lungs.
Duncan C Humphries, Richard A O'Connor, Hazel L Stewart, Tom M Quinn, Erin E Gaughan, Keith Finlayson

Front Immunol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomised controlled trial of intravenous nafamostat mesylate in COVID pneumonitis: Phase 1b/2a experimental study to investigate safety, Pharmacokinetics and Pharmacodynamics.
Tom M Quinn, Erin E Gaughan, Annya Bruce, Jean Antonelli, Richard O'Connor, Keith Finlayson

EBioMedicine· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sub millimetre flexible fibre probe for background and fluorescence free Raman spectroscopy.
Stephanos Yerolatsitis, András Kufcsák, Katjana Ehrlich, Harry A C Wood, Susan Fernandes, Keith Finlayson

J Biophotonics· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progressive impairment in olfactory working memory in a mouse model of Mild Cognitive Impairment.
Jared W Young, John Sharkey, Keith Finlayson

Neurobiol Aging· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
VPAC and PAC receptors: From ligands to function.
Louise Dickson, Keith Finlayson

Pharmacol Ther· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterisation of the Bax-nucleophosmin interaction: the importance of the Bax C-terminus.
Jane Thompson, Keith Finlayson, Eliane Salvo-Chirnside, David MacDonald, James McCulloch

Apoptosis· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of the purinergic P2X7 receptor in inflammation.
Martin F Lister, John Sharkey, Deborah A Sawatzky, Joseph P Hodgkiss, Donald J Davidson, Keith Finlayson

J Inflamm (Lond)· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The odour span task: a novel paradigm for assessing working memory in mice.
Jared W Young, Lorraine E Kerr, John S Kelly, Hugh M Marston, Christopher Spratt, Keith Finlayson

Neuropharmacology· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impaired attention is central to the cognitive deficits observed in alpha 7 deficient mice.
Jared W Young, Nicola Crawford, John S Kelly, Lorraine E Kerr, Hugh M Marston, Keith Finlayson

Eur Neuropsychopharmacol· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A systematic comparison of intracellular cyclic AMP and calcium signalling highlights complexities in human VPAC/PAC receptor pharmacology.
Louise Dickson, Ichiro Aramori, James McCulloch, John Sharkey, Keith Finlayson

Neuropharmacology· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
VIP and PACAP receptor pharmacology: a comparison of intracellular signaling pathways.
Louise Dickson, Ichiro Aramori, John Sharkey, Keith Finlayson

Ann N Y Acad Sci· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acquired QT interval prolongation and HERG: implications for drug discovery and development.
Keith Finlayson, Harry J Witchel, James McCulloch, John Sharkey

Eur J Pharmacol· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nicotine improves sustained attention in mice: evidence for involvement of the alpha7 nicotinic acetylcholine receptor.
Jared W Young, Keith Finlayson, Christopher Spratt, Hugh M Marston, Nicola Crawford

Neuropsychopharmacology· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of effects of MgCl2 and Gpp(NH)p on antagonist and agonist radioligand binding to adenosine A1 receptors.
Keith Finlayson, Takuya Maemoto, Steven P Butcher, John Sharkey, Henry J Olverman

Acta Pharmacol Sin· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis